MyAdvice, a leading provider of software-based marketing solutions for medical, dental and law practices, announced the addition of new functionality to its industry-leading Catalyst website.
Cambridge, Massachusetts-based Acceleron Pharma announced that the company’s Phase II clinical trial of ACE-083 in patients with Charcot-Marie-Tooth disease (CMT) failed to show functional improvement.
Israel’s Nobio Ltd. received approval from the U.S. Food and Drug Administration to market an anti-bacterial composite designed to remain in the teeth for decades.
Environmental factors appear to play a bigger role than genetics in shaping children’s risk for cavities, a study of Australian twins suggests.
